EUVIMEDEUVIMED entdecken
Crossref

Eliakim score performance among patients with active Crohn’s disease

O. Ukashi, A. Lahat, B. Ungar, H. Levy, P. Eidler, S. Ben-Horin, R. Eliakim, U. Kopylov

Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S144

DOI: 10.1055/s-0044-1783003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von O. Ukashi und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Pan-enteric capsule endoscopy [PEC] (PillCam Crohn’s, Medtronic, USA) is a useful tool for disease assessment and monitoring in Crohn’s disease (CD). We have previously demonstrated the reliability and accuracy of Eliakim score (ES) in the assessment of CD-activity among patients with quiescent disease. We aimed to examine the performance of ES among patients who experienced clinical flare, as well as its responsiveness and sensitivity to change during follow-up.

Methods

Patients with CD who have been started on biologics were included. They were prospectively followed with clinical visits, biomarkers and PEC at baseline, and after 14 and 52 weeks. At each time-point Crohn’s disease activity index (CDAI), C-reactive protein (CRP) and fecal-calprotectin (FC) levels were collected, and Lewis score (LS) and ES were calculated (independently reviewed by two experienced readers). Inter-class classification (ICC) was used to asses for agreement between readers. Baseline correlations were obtained using the Spearman's correlation. Repeated-measures correlation (RMC) was calculated using the rmcorr package in R (version 3.3-1). William's test was used to assess difference between correlations.

Results

Seventy-four patients were included (median age of 31.0 [22.5-46.5] years, male–50%). 142 PEC procedures were performed (Baseline– 62, week 14– 58, week 52– 22). Inter-rater agreement between both readers was high for both the LS and ES (ICC of 0.872 [p

Zitieren

APA

Ukashi, O., Lahat, A., Ungar, B., Levy, H., Eidler, P., Ben-Horin, S., Eliakim, R., & Kopylov, U. (2024). Eliakim score performance among patients with active Crohn’s disease. Endoscopy, 56(S 02 S 02), S144. https://doi.org/10.1055/s-0044-1783003

Vancouver

Ukashi O, Lahat A, Ungar B, Levy H, Eidler P, Ben-Horin S, et al. Eliakim score performance among patients with active Crohn’s disease. Endoscopy. 2024;56(S 02 S 02):S144. doi:10.1055/s-0044-1783003

BibTeX
@article{Ukashi2024,
  author = {Ukashi, O. and Lahat, A. and Ungar, B. and Levy, H. and Eidler, P. and Ben-Horin, S. and Eliakim, R. and Kopylov, U.},
  title = {Eliakim score performance among patients with active Crohn’s disease},
  journal = {Endoscopy},
  year = {2024},
  volume = {56},
  number = {S 02 S 02},
  pages = {S144},
  doi = {10.1055/s-0044-1783003}
}
Kostenlos starten →